검색어 : 통합검색[St. Pierre Peter]
총 918건 중 918건 출력
, 86/92 페이지
-
851
- Evidence-based scientific exercise guidelines for adults with spinal cord injury: an update and a new guideline
- Martin Ginis, Kathleen A.; van der Scheer, Jan W.; Latimer-Cheung, Amy E.; Barrow, Andy; Bourne, Chris; Carruthers, Peter; Bernardi, Marco; Ditor, David S.; Gaudet, Sonja; de Groot, Sonja; Hayes, Keith C.; Hicks, Audrey L.; Leicht, Christof A.; Lexell, Jan; Macaluso, Steven; Manns, Patricia J.; McBride, Christopher B.; Noonan, Vanessa K.; Pomerleau, Pierre; Rimmer, James H.; Shaw, Robert B.; Smith, Brett; Smith, Karen M.; Steeves, John D.; Tussler, Dot; West, Christopher R.; Wolfe, Dalton L.; Goosey-Tolfrey, Victoria L.; University of British Columbia, Kelowna, Canada. kathleen_martin.ginis@ubc.ca; ICORD, Vancouver, Canada. kathleen_martin.ginis@ubc.ca; Loughborough University, Loughborough, UK; Queen’s University, Kingston, Canada; Paralympian and Inspirational Speaker, London, UK; Spinal Cord Injury Ontario, Ottawa, Canada; Bromakin Wheelchairs, Loughborough, UK; Sapienza University of Rome, Rome, Italy; Brock University, St. Catharines, Canada; Spinal Cord Injury British Columbia, Vancouver, Canada; University of Groningen, Groningen, The Netherlands; Ontario Neurotrauma Foundation, Toronto, Canada; McMaster University, Hamilton, Canada; Loughborough University, Loughborough, UK; Lund University, Lund, Sweden; Western University, London, Canada; University of Alberta, Edmonton, Canada; Spinal Cord Injury British Columbia, Vancouver, Canada; Rick Hansen Institute, Vancouver, Canada; Institut de Ré adaptation en Dé ficience Physique de Qué bec, Ville de Qué (Spinal cord : the official journal of the International Medical Society of Paraplegia, v.56, 2018, pp.308-321)
-
852
- On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions
- Mü ller, Domenique M. J.; Robe, Pierre A.; Ardon, Hilko; Barkhof, Frederik; Bello, Lorenzo; Berger, Mitchel S.; Bouwknegt, Wim; Van den Brink, Wimar A.; Conti Nibali, Marco; Eijgelaar, Roelant S.; Furtner, Julia; Han, Seunggu J.; Hervey-Jumper, Shawn L.; Idema, Albert J. S.; Kiesel, Barbara; Kloet, Alfred; Mandonnet, Emmanuel; De Munck, Jan C.; Rossi, Marco; Sciortino, Tommaso; Vandertop, W. Peter; Visser, Martin; Wagemakers, Michiel; Widhalm, Georg; Witte, Marnix G.; Zwinderman, Aeilko H.; De Witt Hamer, Philip C.; Department of Neurosurgery, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam; ; Department of Neurology and Neurosurgery, University Medical Center Utrecht; ; Department of Neurosurgery, St. Elisabeth Hospital, Tilburg; ; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands; ; Neurosurgical Oncology Unit, Department of Oncology and Remato-Oncology, Università degli Studi di Milano, Humanitas Research Hospital, IRCCS, Milan, Italy; ; Department of Neurological Surgery, University of California, San Francisco, California; ; Department of Neurosurgery, Medical Center Slotervaart, Amsterdam; ; Department of Neurosurgery, Isala, Zwolle; ; Neurosurgical Oncology Unit, Department of Oncology and Remato-Oncology, Università degli Studi di Milano, Humanitas Research Hospital, IRCCS, Milan, Italy; ; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; ; (Journal of neurosurgery, v.136, 2022, pp.45-55)
-
853
- Efficacy of idelalisib in CLL subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial.
- Sharman, Jeff Porter; Coutre, Steven E.; Furman, Richard R.; Cheson, Bruce D.; Pagel, John M.; Hillmen, Peter; Barrientos, Jacqueline Claudia; Zelenetz, Andrew David; Kipps, Thomas J.; Flinn, Ian; Ghia, Paolo; Hallek, Michael J.; Coiffier, Bertrand; O'Brien, Susan Mary; Tausch, Eugen; Kreuzer, Karl A; Jiang, Wendy; Jahn, Thomas Michael; Lazarov, Mirella; Stilgenbauer, Stephan; Willamette Valley Cancer Institute and Research Center/US Oncology Research, Springfield, OR; Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA; Weill Cornell Medical College, New York, NY; Georgetown University Medical Center, Washington, DC; Fred Hutchinson Cancer Research Center, Seattle, WA; The Leeds Teaching Hospitals, St. James Institute of Oncology, Leeds, United Kingdom; Hofstra North Shore-LIJ School of Medicine, Hempstead, NY; Memorial Sloan Kettering Cancer Center, New York, NY; University of California, San Diego, School of Medicine, San Diego, CA; Sarah Cannon Research Institute, Nashville, TN; Università Vita e Salute; San Raffaele Scientific Institute, Milano, Italy; University of Cologne, Cologne, Germany; Lyon Sud University Hospital, Pierre-Bé nite, France; The University of Texas MD Anderson Cancer Center, Houston, TX; Ulm University, Ulm, Germany; University Hospital Cologne, Cologne, Germany; Gilead Sciences,; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.32, 2014, pp.7011-7011)
-
854
- The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system
- Lu, Xiaowei; le Noble, Ferdinand; Yuan, Li; Jiang, Quingjan; de Lafarge, Benjamin; Sugiyama, Daisuke; Bré ant, Christiane; Claes, Filip; De Smet, Frederik; Thomas, Jean-Lé on; Autiero, Monica; Carmeliet, Peter; Tessier-Lavigne, Marc; Eichmann, Anne; [1] Department of Biological Sciences, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA [2] These authors contributed equally to this work; [1] INSERM U 36, Collè ge de France, 11 Place Marcelin Berthelot, 75005 Paris, France [2] These authors contributed equally to this work; [1] INSERM U 36, Collè ge de France, 11 Place Marcelin Berthelot, 75005 Paris, France [2] These authors contributed equally to this work; [1] INSERM U 36, Collè ge de France, 11 Place Marcelin Berthelot, 75005 Paris, France [2] Present addresses: College of Animal Science, South China Agricultural University, Guangzhou 510642, China (Q.J.); Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA (M.T.-L.); INSERM U 36, Collè ge de France, 11 Place Marcelin Berthelot, 75005 Paris, France; CNRS UMR 7622, Université Pierre et Marie Curie, 9 Quai St Bernard, 75252 Paris, France; INSERM U 36, Collè ge de France, 11 Place Marc; (Nature, v.432, 2004, pp.179-186)
-
855
- Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
- Houssiau, Fré dé ric A.; Vasconcelos, Carlos; D'Cruz, David; Sebastiani, Gian Domenico; Garrido, Enrique de Ramon; Danieli, Maria Giovanna; Abramovicz, Daniel; Blockmans, Daniel; Mathieu, Alessandro; Direskeneli, Haner; Galeazzi, Mauro; Gü l, Ahmet; Levy, Yair; Petera, Peter; Popovic, Rajko; Petrovic, Radmila; Sinico, Renato Alberto; Cattaneo, Roberto; Font, Josep; Depresseux, Geneviè ve; Cosyns, Jean-Pierre; Cervera, Ricard; Cliniques Universitaires St. Luc, Université Catholique de Louvain, Brussels, Belgium; Hospital Santo Antonio, Porto, Portugal; Royal London Hospital, London, UK; Ospedale San Camillo, Rome, Italy; Hospital Regional del SAS de Malaga, Malaga, Spain; Istituto di Clinica Medica, Università degli Study di Ancona, Ancona, Italy; Hô pital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Gasthuisberg Academisch Ziekenhuis, Katholieke Universiteit Leuven, Leuven, Belgium; Università di Cagliari, Cagliari, Italy; University of Marmara Hospital, Istanbul, Turkey; Università degli Studi di Siena, Siena, Italy; University of Istanbul, Istanbul, Turkey; Chaim Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel; Lainz Hospital, Vienna, Austria; Military Medical Academy, Belgrade, Yugoslavia; University of Belgrade, Belgrade, Yugoslavia; Ospedale Policlinico, Ospedale San Carlo Borromeo, Milan, Italy; Ospedale Civile, Univ; (Arthritis and rheumatism, v.46, 2002, pp.2121-2131)
-
856
- THU181 Evaluation Of Bone Mineral Density In A Cohort Of Children With ACH Participating In The PROPEL 2 Study Of Infigratinib
- Savarirayan, Ravi; De Bergua, Josep Maria; Arundel, Paul; Salles, Jean Pierre; Leiva-Gea, Antonio; Irving, Melita; Saraff, Vrinda; McDevitt, Helen; Salcedo, Maria; Nicolino, Marc P; Cormier-Daire, Valerie; Kannu, Peter; Skae, Mars; Bober, Michael B; Phillips III, John; Candler, Toby; Harmatz, Paul; Saal, Howard; Hoover-Fong, Julie; Muslimova, Elena; Cho, Terry; Weng, Richard; Rogoff, Daniela; Murdoch Children’s Research Institute , Melbourne , Australia; Hospital Vithas San José , Vitoria-Gasteiz , Spain; Sheffield Children’s NHS Foundation Trust , Sheffield , United Kingdom; Children Hospital, Toulouse University Hospital , Toulouse , France; Instituto de Investigació n Biomé dica de Má laga - IBIMA, and Hospital Universitario Virgen de la Victoria , Malaga , Spain; Guy’s and St Thomas’ NHS Trust , London , United Kingdom; Birmingham Women’s and Children’s NHS Foundation Trust , Birmingham , United Kingdom; NHS Greater Glasgow and Clyde , Glasgow , United Kingdom; Hospital Universitario La Paz , Madrid , Spain; Hô pital Femme Mè re Enfant , Hospices Civils de Lyon, Lyon , France; Imagine Institute, Hô pital Necker-Enfants Malades, University of Paris , Paris , France; Department of Medical Genetics, University of Alberta , Edmonton, AB , Canada; Manchester University NHS Foundation Trust, University of Manche; (Journal of the endocrine society, v.7, 2023, pp.bvad114.1432)
-
857
- Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
- Cohen, Alexander T.; Ay, Cihan; Hainaut, Philippe; Dé cousus, Hervé ; Hoffmann, Ulrich; Gaine, Sean; Coppens, Michiel; da Silva, Pedro Marques; Castro, David Jimenez; Amann-Vesti, Beatrice; Brü ggenjü rgen, Bernd; Levy, Pierre; Bastida, Julio Lopez; Vicaut, Eric; Laeis, Petra; Fronk, Eva-Maria; Zierhut, Wolfgang; Malzer, Thomas; Bramlage, Peter; Agnelli, Giancarlo; Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, London, UK; Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Department of General Internal Medicine, Cliniques Universitaires Saint Luc, UCL, Bruxelles, Belgium; Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest En Jarez, France; Division of Angiology, Medical Clinic IV, University Hospital, Ludwig-Maximilians-University, Munich, Germany; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Arterial Investigation Unit, Hospital de Santa Marta, Lisbon, Portugal; Respiratory Department, Ramó n y Cajal Hospital, Madrid, Spain; Division of Angiology, University Hospital Zurich, Zurich, Switzerland; Institute for Health Economics, Steinbeis-University, B; (Thrombosis journal, v.16, 2018, pp.9)
-
858
- Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12–14, 2018
- Hawthorne, Wayne J.; Cowan, Peter J.; Bü hler, Lé o H.; Yi, Shounan; Bottino, Rita; Pierson III, Richard N.; Ahn, Curie; Azimzadeh, Agnes; Cozzi, Emanuele; Gianello, Pierre; Lakey, Jonathan R. T.; Luo, Minhua; Miyagawa, Shuji; Mohiuddin, Muhammad M.; Park, Chung‐ Gyu; Schuurman, Henk‐ Jan; Scobie, Linda; Sykes, Megan; Tector, Joseph; Tö njes, Ralf Reinhard; Wolf, Eckhard; Nuñ ez, José R.; Wang, Wei; Department of Surgery, Westmead Hospital, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Sydney Medical School, University of Sydney, Westmead, New South Wales, Australia; Immunology Research Centre, St Vincent's Hospital, Melbourne, Victoria, Australia; University Hospitals Geneva, Geneva, Switzerland; Center for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia; Allegheny Health Network - Carnegie Mellon University, Pittsburgh, Pennsylvania; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Division of Nephrology, College of Medicine, Seoul National University, Seoul, South Korea; Department of Surgery, Massachusetts; (Xenotransplantation, v.26, 2019, pp.e12513)
-
859
- An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: a randomized sham-controlled clinical trial
- Gilligan, Christopher; Volschenk, Willem; Russo, Marc; Green, Matthew; Gilmore, Christopher; Mehta, Vivek; Deckers, Kristiaan; De Smedt, Kris; Latif, Usman; Georgius, Peter; Gentile, Jonathan; Mitchell, Bruce; Langhorst, Meredith; Huygen, Frank; Baranidharan, Ganesan; Patel, Vikas; Mironer, Eugene; Ross, Edgar; Carayannopoulos, Alexios; Hayek, Salim; Gulve, Ashish; Van Buyten, Jean-Pierre; Tohmeh, Antoine; Fischgrund, Jeffrey; Lad, Shivanand; Ahadian, Farshad; Deer, Timothy; Klemme, William; Rauck, Richard; Rathmell, James; Levy, Robert; Heemels, Jan Pieter; Eldabe, Sam; Division of Pain Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, MA, United States,; Hunter Pain Specialists, Newcastle, Australia; Hunter Pain Specialists, Newcastle, Australia; Pain Medicine of SA, Adelaide, Australia; Center for Clinical Research, Carolinas Pain Institute, Winston-Salem, NC, United States; Barts Neuromodulation Centre, St. Bartholomew's Hospital, London, United Kingdom; Department of Physical Medicine and Rehabilitation, GZA - Sint Augustinus Hospital, Wilrijk, Belgium; Department of Neurosurgery, GZA - Sint Augustinus Hospital, Wilrijk, Belgium; Department of Anesthesiology, University of Kansas School of Medicine, Kansas City, KS, United States; Sunshine Coast Clinical Research, Noosa Hea; (Pain, v.162, 2021, pp.2486-2498)
-
860
- Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
- Garcia-Manero, Guillermo; Fenaux, Pierre; Al-Kali, Aref; Baer, Maria R; Sekeres, Mikkael A; Roboz, Gail J; Gaidano, Gianluca; Scott, Bart L; Greenberg, Peter; Platzbecker, Uwe; Steensma, David P; Kambhampati, Suman; Kreuzer, Karl-Anton; Godley, Lucy A; Atallah, Ehab; Collins Jr, Robert; Kantarjian Jr, Hagop; Jabbour Jr, Elias; Wilhelm Jr, Francois E; Azarnia Jr, Nozar; Silverman Jr, Lewis R; University of Texas MD Anderson Cancer Center, Department of Leukemia; Hô pital St Louis/Université Paris 7; Mayo Clinic; University of Maryland, Greenebaum Cancer Center; Leukemia Program, Cleveland Clinic; Weill Cornell Medical College; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont; Fred Hutchinson Cancer Research Center; Stanford Cancer Center; Universitä tsklinikum Dresden, Medizinische Klinik und Poliklinik I; Dana Farber Cancer Institute; University of Kansas Medical Center; Universitä tsklinikum zu Kö ln, Klinik I fü r Innere Medizin; University of Chicago Medical Center; (The Lancet. Oncology, v.17, 2016, pp.496-508)
QUICK MENU
